KVUE Kenvue Inc.
Kenvue Inc. (KVUE) trend channel, buy level and 3-month target on Trade The Path. Sector: Consumer Defensive. Listed on NYSE. There is not a clean channel on this listing yet, so we publish no buy/sell numbers and do not index this URL. Quote and company profile remain visible.
No trend channel yet
There is not enough price history for this listing to fit trend lines — it is newly listed, thinly traded, or not yet covered by our data provider. Everything else on this page still works: you can add it to your watchlist and we will fit the channel automatically once enough daily prices have built up. Telegram alerts stay off for this one until then.
Price history
- Daily close
No trade suggested right now
There is not yet a channel we can put a buy and a target on.
About Kenvue Inc.
Kenvue Inc. functions as a global leader in the consumer health sector. The company structures its operations across three primary divisions: Self Care, Skin Health and Beauty, and Essential Health. Within the Self Care unit, it offers a diverse range of products for common conditions like coughs, colds, and allergies, in addition to pain relief, digestive health, and smoking cessation aids, featuring prominent brands such as Tylenol, Nicorette, and Zyrtec. The Skin Health and Beauty segment delivers various solutions for facial, body, hair, and sun protection, recognized under popular labels including Neutrogena, Aveeno, and OGX. Moreover, the Essential Health category provides oral hygiene, infant care, feminine wellness, and wound treatment products, marketed through esteemed brands like Listerine, Johnson's, Band-Aid, and Stayfree. Established in 2022, Kenvue Inc. maintains its corporate headquarters in Skillman, New Jersey, and operates as a subsidiary of Johnson & Johnson.
- Sector
- Consumer Defensive
- Industry
- Household & Personal Products
- CEO
- Kirk L. Perry
- Employees
- 21,890
- Country
- US
Scorecard
Our own pillar scores, computed from the fundamentals below. They are not Morningstar ratings — that data is licensed and we do not redistribute it.
- Valuation
- —
- Profitability
- —
- Financial health
- —
- Cash generation
- —
Key statistics
- Market cap
- US$34.14B
- Enterprise value
- —
- Beta
- 0.43
- Avg volume
- 20.78M
- Revenue per share
- —
- Dividend yield
- —
- 52-week range
- 14.02-20.13
- Exchange
- NYSE
Key ratios
- P/E (TTM)
- —
- PEG
- —
- Price / sales
- —
- Price / book
- —
- EV / EBITDA
- —
- Gross margin
- —
- Operating margin
- —
- Net margin
- —
- Current ratio
- —
- Quick ratio
- —
- Debt / equity
- —
- Interest cover
- —
Income statement
Balance sheet
Cash flow
Trend lines are fitted statistically to past swing highs and lows and projected forward on the assumption the same rhythm continues. It often does not. This is information, not advice.